Introduction {#S0001}
============

Salivary adenoid cystic carcinoma (SACC) is a frequent subtype of salivary gland malignancy, which accounts for 25% of malignant tumors in the major salivary glands and 10% of all head and neck carcinomas \[[@CIT0001]\]. Salivary adenoid cystic carcinoma is characterized by slow growth but high incidence of distant metastasis, particularly to the lungs. Distant metastasis occurs in 25--50% of patients and commonly in lungs but less commonly in the liver and bone \[[@CIT0002], [@CIT0003]\]. However, the reason for the invasiveness and metastatic dissemination of SACC remains unclear.

Although not well understood for molecular mechanisms of cancer metastasis, angiogenesis might be a possible mechanism involved \[[@CIT0004]\]. Angiogenesis is the development of new blood vessels and an important process occurring in tumor growth and metastasis. The process is intricately regulated by multiple angiogenic cytokines and other factors released by tumor cells in different pathways, such as vascular endothelial growth factor (VEGF), angiopoietin-1, basic fibroblast growth factor, platelet-derived growth factor receptor, stem cell factor receptor (c-Kit), and transforming growth factor-β1 (TGF-β1) \[[@CIT0005], [@CIT0006]\]. As the most notable angiogenic factor, VEGF has been shown to be highly expressed in SACC, and its expression is associated with tumor size, invasion and metastasis \[[@CIT0007]--[@CIT0009]\]. Furthermore, recent studies have indicated that overexpression of inducible nitric oxide synthase and nuclear factor κB could contribute to angiogenesis by up-regulation of VEGF in many cancers \[[@CIT0010], [@CIT0011]\]. Additionally, c-Kit receptor, also known as CD117, was originally identified as an oncoprotein encoded by a feline sarcoma virus. Its activation would induce diverse intracellular responses such as mitogen-activated protein kinase (MAPK) and phosphoinositide-3 kinase (PI3K/Akt) pathways \[[@CIT0012]\]. Thus, c-Kit regulates blood cell survival and growth control via the aforementioned two pathways. As a result, VEGF and c-Kit have been used as targets of molecule inhibitors for treatment of SACC \[[@CIT0013], [@CIT0014]\]. Disappointingly, the mechanism of tumorigenesis and metastasis of SACC is not clearly elucidated and therapeutic targets are rare in clinical therapy. Because conventional chemotherapy has a poor effect in the treatment of SACC, there is a great interest in determining the molecular abnormalities in SACC.

To gain further insight into the molecular mechanism of tumorigenesis, bioinformatics and microarray are widely used in the study of cancers by researchers. However, microarray analysis is not well utilized in improving therapeutic outcomes for SACC. With the hope that doing so will achieve the goal of discovering an effective targeted therapy, we identified differentially expressed genes (DEGs) between a low metastatic SACC cell line (ACC-2) and a highly metastatic SACC cell line (ACC-M), which was screened from ACC-2 by combination of *in vivo* selection and cloning *in vitro* \[[@CIT0015]\]. Since ACC-2 and ACC-M cells share an identical genetic background except for different metastatic behavior, it is presumed that the DEGs are metastasis-related genes, which play direct or indirect roles in the progression of metastasis. Then the DEGs were analyzed by Gene Ontology (GO) functions and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Then, a protein-protein interaction (PPI) network was built for DEGs. Taken together, the gene signature of metastasis could be helpful to develop novel therapeutic strategies in SACC patients.

Material and methods {#S0002}
====================

RNA extraction and probe preparation {#S20003}
------------------------------------

Total RNA from ACC-M and ACC-2 cells was isolated using the TRIzol method according to the manufacturer\'s (Invitrogen) instructions. RNA quality from each cell line was assessed by visualization of the 28S/18S ribosomal RNA ratio on 1% agarose gel. Total RNA samples were subjected to Human OneArray v6.1 (Phalanx Biotech, Taiwan, China), and all procedures were carried out according to the protocol. Briefly, 0.5 µg of RNA from two cell lines was labeled with a Cy3 fluorophore and labeled RNAs were hybridized at 37°C overnight.

Data preprocessing {#S20004}
------------------

The intensity of each probe was processed and normalized by the median scaling normalization method. In order to ensure that a probe was specific for one gene, we eliminated probes with multiple matching gene sequences. When several probes hybridized with transcripts from one gene, we calculated the mean values as the probe value. Normalized intensities were transformed to gene expression log2 ratios between ACC-M and ACC-2.

DEG screening {#S20005}
-------------

Because there was no extra replication except for one control group and one experimental group, we applied intensity alignment of probes between ACC-M and ACC-2 to identify DEGs. Genes with log fold change (FC) \> 1 were considered to be significant.

GO function and KEGG pathway enrichment analysis {#S20006}
------------------------------------------------

To identify gene functions enriched in ACC-M, we performed GO \[[@CIT0016]\] function enrichment analysis for DEGs in 3 functional ontologies: biological process (BP), cellular component (CC) and molecular function (MF). KEGG pathway \[[@CIT0017]\] enrichment analysis was also performed to identify significant pathways enriched in ACC-M with a platform developed by Feng-He Information Technology Co., Ltd (Shanghai, China). The *p*-value was calculated by hypergeometric distribution and a pathway with *p* \< 0.01 was considered as significant.

Function annotation for DEGs {#S20007}
----------------------------

To ensure whether DEGs function in transcriptional regulation, transcription factor analysis was employed by mapping DEGs to the intersection between the TRANSFAC \[[@CIT0018]\] and transcription activity term of the GO database. Combined with Tumor Suppressor Gene (TSG) \[[@CIT0019]\] and Tumor Associated Gene (TAG) \[[@CIT0020]\] databases, we also obtained known oncogenes and suppressor genes from identified DEGs.

Construction of PPI network {#S20008}
---------------------------

To study protein-protein association information for DEGs, the STRING database \[[@CIT0021]\] was used to construct the PPI network. The selected protein pairs in PPI with an association score more than 0.9 and the number of nodes more than 3 were products of DEGs.

Results {#S0009}
=======

DEG identification {#S20010}
------------------

To identify significant genes between ACC-M and ACC-2, DEG identification was performed. A total of 1128 DEGs were obtained including 448 up- and 680 down-regulated DEGs.

GO function enrichment analysis {#S20011}
-------------------------------

To study the function changes in the process of tumor metastasis, we identified over-presented GO categories in BP, CC and MF for both up- and down-regulated DEGs. The top 5 categories for 3 type GO terms are listed in [Tables I](#T0001){ref-type="table"}--[III](#T0003){ref-type="table"}. From the results, up-regulated DEGs were mainly enriched in "reflex" and "synaptic transmission glycinergic" in BP, "extracellular region" and "integral to mitochondrial membrane" in CC, and "inhibitory extracellular ligand-gated ion channel activity" in MF. Down-regulated DEGs were mainly enriched in "adenylate cyclase-activating G-protein coupled receptor signaling pathway" in BP, "plasma membrane-related functions" in CC and "G-protein coupled amine receptor activity" in MF.

###### 

Gene Ontology function enrichment analysis for both up- and down-regulated differentially expressed genes in Biological Process (top 5 GO terms were listed)

  GO-ID                                                     GO-term                                                                     Clustered gene numbers                        Typical gene symbol                      *P*-value
  ---------------- ---------------------------------------- --------------------------------------------------------------------------- --------------------------------------------- ---------------------------------------- -----------
  Up-regulated     GO:0060004                               Reflex                                                                      4                                             GJA1, GLRA1, GLRB, NPNT                  0.00026
  GO:0060012       Synaptic transmission, glycinergic       2                                                                           GLRA1, GLRB                                   0.00042                                  
  GO:0046903       Secretion                                32                                                                          CD274, MMP7, PRKAR1A, TRPC1WNK4, WNT5A        0.00057                                  
  GO:0043030       Regulation of macrophage activation      4                                                                           BPI, IL4, SNCA, WNT5A                         0.00115                                  
  GO:0006888       ER to Golgi vesicle-mediated transport   6                                                                           INSIG1, LMAN1, SAR1B, SEC23A, SEC23B, SPAST   0.00120                                  
  Down-regulated   GO:0007189                               Adenylate cyclase-activating G-protein coupled receptor signaling pathway   9                                             ADCY1, ADCY3, ADRB1, ADRB2, OPRM1, VIP   2.08E-05
  GO:0051046       Regulation of secretion                  31                                                                          IL1A, TGF-β1, CORIN, FAM3D, TNFSF15,TRAF6     7.08E-05                                 
  GO:0002526       Acute inflammatory response              13                                                                          APOL2, CD163, IL1A, IL20RB, VCAM1, VTN        7.23E-05                                 
  GO:0019233       Sensory perception of pain               10                                                                          NTRK1, OPRD1, ADRB1,CHRNB2, P2RX4, VIP        8.45E-05                                 
  GO:0051049       Regulation of transport                  55                                                                          IL1A, TGF-β1, BCL2, BEST1, PIK3R1, TRIB3      0.00021                                  

###### 

Gene Ontology function enrichment analysis for both up- and down-regulated differentially expressed genes in Cellular Component (top 5 GO terms were listed)

  GO-ID                                                 GO-term                        Clustered gene numbers                        Typical gene symbol                       *P*-value
  ---------------- ------------------------------------ ------------------------------ --------------------------------------------- ----------------------------------------- -----------
  Up-regulated     GO:0005576                           Extracellular region           70                                            CCL20, CD274, IGSF10, MMP7, NGFR, WNT5A   0.00040
  GO:0032592       Integral to mitochondrial membrane   4                              CPT1A, ETFDH, MFF, TMEM70                     0.00528                                   
  GO:0044421       Extracellular region part            38                             CCL20, CD274, IL4, MMP26, MMP7, WNT5A         0.00539                                   
  GO:0031301       Integral to organelle membrane       11                             A4GALT, CPT1A, HSPA5, INSIG1, QSOX1, TMEM70   0.00573                                   
  GO:0005593       FACIT collagen                       2                              COL14A1, COL16A1                              0.00655                                   
  Down-regulated   GO:0031226                           Intrinsic to plasma membrane   62                                            ADAM29, ADCY3, CCR9, CD163, NTRK1, TPO    0.00048
  GO:0005887       Integral to plasma membrane          59                             ADAM29, ADCY3CCR9, CD163, NTRK1, TACR2        0.00089                                   
  GO:0044459       Plasma membrane part                 84                             ADAM29, ADCY3, CCR9, CD163, NTRK1, OPRD1      0.00143                                   
  GO:0044304       Main axon                            6                              ADORA2A, MYO1D, NCMAP, ROBO1, SCN8A, SPOCK1   0.00253                                   
  GO:0005576       Extracellular region                 90                             CCL16, CD163, IL1A, IL22, TEK, TGF-β1         0.00299                                   

###### 

Gene Ontology function enrichment analysis for both up- and down-regulated differentially expressed genes in Molecular Function (top 5 GO terms were listed)

  GO-ID                                                                    GO-term                                                      Clustered gene numbers                             Typical gene symbol                        *P*-value
  ---------------- ------------------------------------------------------- ------------------------------------------------------------ -------------------------------------------------- ------------------------------------------ -----------
  Up-regulated     GO:0005237                                              Inhibitory extracellular ligand-gated ion channel activity   3                                                  GABRB2, GLRA1, GLRB                        8.71E-05
  GO:0016933       Extracellular-glycine-gated ion channel activity        2                                                            GLRA1, GLRB                                        0.00253                                    
  GO:0016934       Extracellular-glycine-gated chloride channel activity   2                                                            GLRA1, GLRB                                        0.00253                                    
  GO:0015276       Ligand-gated ion channel activity                       9                                                            CNGA3, GABRA1, GLRB, P2RX2, TRPC1, TRPC5           0.00256                                    
  GO:0022834       Ligand-gated channel activity                           9                                                            CNGA3, GABRA1, GLRB, P2RX2, TRPC1, TRPC5           0.00256                                    
  Down-regulated   GO:0008227                                              G-protein coupled amine receptor activity                    6                                                  ADRB1, ADRB2, HTR1A, HTR2A, TAAR2, TAAR6   0.00227
  GO:0004939       β-Adrenergic receptor activity                          2                                                            ADRB1, ADRB2                                       0.00298                                    
  GO:0004867       Serine-type endopeptidase inhibitor activity            9                                                            CPAMD8, OVOS, SERPINA1, SERPINA5, SPINK9, SPOCK1   0.00327                                    
  GO:0004252       Serine-type endopeptidase activity                      12                                                           CORIN, F11, PRSS54, ST14, MST1L, PCSK5             0.00328                                    
  GO:0051537       2 iron, 2 sulfur cluster binding                        4                                                            AIFM3, CISD3, GLRX2, NDUFS1                        0.00329                                    

KEGG pathway enrichment analysis {#S20012}
--------------------------------

To gain further insight into the function of DEGs, we used the platform developed by Feng-He Information Technology Co., Ltd (Shanghai, China) to identify the significant pathways. With the selected criteria we finally obtained 9 pathways ([Table IV](#T0004){ref-type="table"}). The up-regulated DEGs were mainly enriched in the "protein processing in endoplasmic reticulum" pathway, while down-regulated DEGs were significantly enriched in "Calcium signaling pathway" and "Olfactory transduction". From the pathway information in the KEGG database, we found that just "Apoptosis" and "Cytokine-cytokine receptor interaction" pathways were associated with tumorigenesis.

###### 

Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis for both up- and down-regulated differentially expressed genes

  KEGG-ID                                                    KEGG-term                                     Clustered gene numbers                          Typical gene symbol                          *P*-value
  ---------------- ----------------------------------------- --------------------------------------------- ----------------------------------------------- -------------------------------------------- -----------
  Up-regulated     KEGG:4141                                 Protein processing in endoplasmic reticulum   11                                              HSPA2, HSPA5, HSPA8, LMAN1, MAN1A1, PDIA4    0.00063
  Down-regulated   KEGG:4020                                 Calcium signaling pathway                     15                                              ADCY1, ADCY3, ATP2B1, GRIN2C, HTR2A, P2RX1   0.00047
  KEGG:4740        Olfactory transduction                    24                                            ADCY3, OR1A2, OR1L8, OR2A14, OR2G3, OR2V2       0.00120                                      
  KEGG:4210        Apoptosis                                 9                                             TGF-β1, IFNA1, NTRK1, PIK3R1, PIK3R2, TNFSF10   0.00167                                      
  KEGG:4080        Neuroactive ligand-receptor interaction   18                                            ADRB1, ADRB2, CHRNB2, F2, GRID1, GRIN2C         0.00243                                      
  KEGG:4910        Insulin signaling pathway                 11                                            G6PC2, IRS1, PCK2, PIK3R1, PIK3R2, SHC2         0.00434                                      
  KEGG:4540        Gap junction                              8                                             ADCY1, ADCY3, ADRB1, HTR2A, PDGFC, PLCB         0.00761                                      
  KEGG:5414        Dilated cardiomyopathy                    8                                             TGF-β1, PRKACG, ADCY1, ADCY3, ADRB1, TNNT2      0.00761                                      
  KEGG:4060        Cytokine-cytokine receptor interaction    16                                            TGF-β1, IFNA1, NTRK1, CCL16, CCR9, TNFSF10      0.00998                                      

Function annotation of DEGs {#S20013}
---------------------------

Combined with genes in Tumor Suppressor Gene (TSG) and Tumor Associated Gene (TAG) databases, we screened known tumor suppressor genes and oncogenes in both up- and down-regulated DEGs. In 25 DEGs enriched in tumor-related "Apoptosis" and "Cytokine-cytokine receptor interaction" pathways, we found that IFN-α1 (interferon α1) was a tumor suppressor gene but neurotrophic tyrosine kinase, receptor, type 1 (NTRK1) was an oncogene. Just transforming growth factor β1 (TGF-β1) was associated with lung diseases but not with transcriptional regulatory function.

Protein-protein interaction network {#S20014}
-----------------------------------

After PPI network construction with the criteria of an association score higher than 0.9 and the number of nodes more than 3, we selected 32 differentially expressed proteins in the network ([Figure 1](#F0001){ref-type="fig"}). Moreover, there were 3 DEGs with the number of nodes higher than 10 including 2 up-regulated proteins -- phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit α (PIK3CA) and protein tyrosine phosphatase, non-receptor type 11 (PTPN11) -- and one down-regulated protein, phosphoinositide-3-kinase, regulatory subunit 1α (PIK3R1).

![Protein-protein interaction network for differentially expressed genes. Red color represents up-regulated genes, and green color represents down-regulated genes. Diamonds represent genes with the number of nodes more than 10. Square represents oncogene which associates with "Apoptosis" and "Cytokine-cytokine receptor interaction" pathways](AMS-12-27890-g001){#F0001}

Discussion {#S0015}
==========

Salivary adenoid cystic carcinoma is a common malignant tumor that arises from the secretory epithelial cells of salivary glands and has a unique potential for cell invasion and distant migration, particularly to the lungs. To date, there are very few prospective studies of molecular biomarkers which can be used to predict prognosis of SACC or therapeutic response. In this study, DEGs were screened from a highly metastatic cell line (ACC-M) compared with a low metastatic cell line (ACC-2), followed by functional annotation and PPI network construction for DEGs. DEGs were significantly enriched in "Apoptosis" and "Cytokine-cytokine receptor interaction" pathways which were associated with tumors in the KEGG database, which involved 3 significant DEGs: NTRK1, IFNA1 and TGF-β1. Moreover, PIK3CA, PIK3R1 and PTPN11 were also important for SACC in the PPI network.

Transforming growth factor β1 is a multifunctional polypeptide which plays vital roles in apoptosis, cell proliferation and epithelial-mesenchymal transition \[[@CIT0022]--[@CIT0026]\]. Previous studies have suggested that TGF-β1 signaling could promote invasion and metastasis of breast cancer and glioma \[[@CIT0027], [@CIT0028]\]. In addition, it has been proved that overexpression of active TGF-β1 *in vivo* accelerates lung metastases of transgenic mammary tumors with an effect on tumor size or tumor cell proliferation \[[@CIT0029]\]. Moreover, it was found that TGF-β1 expression was significantly increased in human primary SACC samples with metastasis \[[@CIT0030]\]. Further study showed that TGF-β1 could promote migration and invasion of SACC via TGF-β1/Smad signaling and induce epithelial-mesenchymal transition in normal stromal cells or epithelial cells of SACC \[[@CIT0031]\]. On the other hand, TGF-β1 is a pluripotent cytokine with dual roles and is also considered as a tumor suppressor in tumorigenesis \[[@CIT0032]\]. Inconsistent with the previous study, our microarray test showed that TGF-β1 was down-regulated in a highly metastatic SACC cell line. From the results of pathway enrichment analysis, TGF-β1 was found to be enriched in the "Cytokine-cytokine receptor interaction" pathway. Interaction between the cytokine and cytokine receptor leads to multiple biological responses including prevention of tumor cell apoptosis and cell survival \[[@CIT0033]\]. As a result, we speculate that a decrease of the cytokine TGF-β1, as a tumor suppressor, regulates lung metastasis of SACC through the "cytokine-cytokine receptor interaction" pathway.

NTRK1, as a high affinity receptor for nerve growth factor (NGF), is a member of the neurotrophin receptor family. After binding with NGF, NTRK1 undergoes dimerization and autophosphorylation of tyrosine residues \[[@CIT0034]\]. Then apoptosis, proliferation and differentiation-related proteins including phosphatidylinositol 3-kinase, Rac, Ras and mitogen activated protein kinase, respectively, are activated \[[@CIT0035]\]. These proteins can stimulate apoptosis of tumor cells. In our study, NTRK1 was found to be down-regulated and enriched in the pathway "Apoptosis". As a result, decreased NTRK1 may contribute to anti-apoptosis of cancer cells and tumorigenesis. Additionally, NTRK2 has been found to be implicated in the pathogenesis of lung cancers \[[@CIT0036]\]. Thus, NTRK2 may be associated with lung metastasis of SACC.

INF-α1, a member of the interferon family, is known as a tumor suppressor gene. A previous study showed that the cytokine mediates its apoptotic effects by inducing expression of a tumor necrosis factor (TNF)-related apoptosis-inducing ligand \[[@CIT0037]\]. Thus, down-regulated INF-α1 may accelerate tumor development. PIK3CA encodes the p110α catalytic subunit of phosphatidylinositol-3-kinase (PI3K), which has been shown to be expressed in cancers, such as lung and ovarian cancer \[[@CIT0038], [@CIT0039]\]. Previous studies have indicated that PIK3CA is regulated by transcription factor p53, which is involved in apoptosis and cell cycle arrest \[[@CIT0040]\]. Moreover, inactivation of p53 leads to up-regulation of PIK3CA and appears to be an early step in ovarian carcinogenesis \[[@CIT0039]\]. Furthermore, PIK3CA has been used as a candidate target for inhibition of metastatic tumor growth in bone-metastatic tumors \[[@CIT0041]\]. Consequently, we infer that PIK3CA might be associated with lung metastasis in SACC.

In conclusion, we have identified several DEGs with change of expression in SACC. Transforming growth factor-β1 might be a unique molecule in lung metastasis and could be selected as a candidate target for clinical therapy. NTRK1, IFNA1 and PIK3CA are also associated with tumor development of SACC. Nevertheless, a limitation has to be mentioned. There is no biological replicate in the study. The analysis is merely a qualitative experiment, but it can partly elucidate molecular mechanisms of lung metastasis of SACC. Further experiments are needed, enrolling more biological replicates and verifying the results of bioinformatics.
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